Open13.720 | Close14.260 |
Vol / Avg.143.026K / 365.971K | Mkt Cap490.490M |
Day Range13.500 - 14.490 | 52 Wk Range10.470 - 31.450 |
RAPT Therapeutics Stock (NASDAQ: RAPT) stock price, news, charts, stock research, profile.
Open13.720 | Close14.260 |
Vol / Avg.143.026K / 365.971K | Mkt Cap490.490M |
Day Range13.500 - 14.490 | 52 Wk Range10.470 - 31.450 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.750 | -0.820 | -0.0700 | ||||
REV | 0 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.800 | -0.660 | 0.1400 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-15 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 41.00 |
2023-09-14 | Berenberg | Andy Chen | Initiates Coverage On | Buy | Announces | - | 34.00 |
2023-08-16 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Lowers | 39.00 | 32.00 |
2023-08-14 | Piper Sandler | Edward Tenthoff | Maintains | OverweightOverweight | Raises | 28.00 | 31.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
RAPT | RAPT Therapeutics | 3.11% | 490.5M |
MGNX | Macrogenics | -3.4% | 458.4M |
SPRY | ARS Pharmaceuticals | -5.77% | 423.3M |
RNA | Avidity Biosciences | 14.61% | 523.2M |
BLUE | bluebird bio | -0.26% | 418.8M |
You can purchase shares of RAPT Therapeutics (NASDAQ: RAPT) through any online brokerage.
Other companies in RAPT Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), Avidity Biosciences (NASDAQ:RNA), bluebird bio (NASDAQ:BLUE) and 4D Molecular Therapeutics (NASDAQ:FDMT).
The latest price target for RAPT Therapeutics (NASDAQ: RAPT) was reported by HC Wainwright & Co. on Wednesday, November 15, 2023. The analyst firm set a price target for 41.00 expecting RAPT to rise to within 12 months (a possible 187.52% upside). 18 analyst firms have reported ratings in the last year.
The stock price for RAPT Therapeutics (NASDAQ: RAPT) is $14.26 last updated November 28, 2023 at 9:00 PM UTC.
There is no dividend information for RAPT Therapeutics.
RAPT Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for RAPT Therapeutics.
RAPT Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.